Welcome to the e-CCO Library!

P202: De novo Inflamatory Bowel Disease after solid organ transplantation
Year: 2021
Source: ECCO'21 Virtual
Authors: Luque Carmona, A.M.(1);Rojas Feria, M.(1);De la Cruz Ramirez, M.D.(1);Trigo Salado, C.(1);Herrera Justiniano, J.M.(1);Leo Carnerero, E.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P202: Diagnosis of inflammatory bowel disease in asymptomatic subjects: disease characteristics, natural history and treatment requirements
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Rodríguez-Lago I.*1, Merino O.2, Azagra I.3, Maiz A.4, Zapata E.5, Higuera R.6, Fernández-Calderόn M.7, Iriarte A.8, Arreba P.9, Carrascosa J.10, Montalvo I.11, Portillo I.12, Aguirre U.13,14, Cabriada J.L.1 IBD Study Group of the Basque–Navarre Society of Gastrointestinal Diseases, Pais Vasco-Navarra, Spain1,2,3,4,5,6,7,8,9,10,11

Created: Wednesday, 20 February 2019, 10:36 AM
P202: Diagnostic accuracy of new non-invasive biomarkers for the evaluation of ulcerative colitis activity
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Abdulganieva1*, D. Mukhametova1, A. Odintsova2

Created: Thursday, 21 February 2019, 9:14 AM
P202: Meta-analysis: accuracy of interferon-γ release assays in differentiating intestinal tuberculosis from Crohn’s disease in Asia
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

H. Xu*1, Y. Li2, J. Qian2

Created: Friday, 22 February 2019, 9:49 AM
P202: Performance characteristics of serum FGF19 measurement compared with the Se-HCAT retention test in the diagnosis of bile acid diarrhoea in Crohn’s Disease
Year: 2022
Source: ECCO'22
Authors: Ruiz-Cerulla, A.(1);Blat Serra, R.(1);Sánchez-Pastor, E.(1);Notta, P.C.(2);Rodríguez-Alonso, L.(1);Aràjol Gonzalez, C.(1);Serra Nilsson, K.(1);Antón Güell, S.(1);Serrano Santacruz, I.(3);Luque Gómez , A.(3);Aran, J.M.(3);Rodríguez-Moranta, F.(1);Guardiola Capon, J.(1);
Created: Friday, 11 February 2022, 3:52 PM
P202: Quantum blue anti-infliximab: development and evaluation of a point of care rapid test for measuring anti-infliximab antibodies in human serum
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. Bantleon1, M. Schneider*1, B. Ricken1, S. Velayutham1, D. Trapani1, J. Afonso2, F. Magro2, A. Abel1

Created: Friday, 22 February 2019, 9:41 AM
P203 FIT and FC as a surrogate non-invasive marker for mucosal healing in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.S. ISMAIL, G. Murphy, C. Kelly, F. O’Riordan, S. Semenov, S. Sihag, N. Breslin, O. Anthony, B. Ryan, D. McNamara, Trinity Academic Gastroenterology Group Trinity College Dublin

Created: Thursday, 30 January 2020, 10:12 AM
P203: Duodenal lesions in postoperative ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Sako*, N. Yoshimura, M. Takazoe

Created: Friday, 22 February 2019, 9:49 AM
P203: Factors associated with restless legs syndrome in patients with ulcerative colitis: a study in a tertiary care center in Romania
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Popa R.C.*1, Savin A.1, Ungureanu I.1, Gavrilescu O.1,2, Dranga M.1,2, Chiosa A.M.1, Jigaranu O.1, Popa I.1, Mihai C.1,2, Cijevschi-Prelipcean C.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P203: Oral omeprazole and diclofenac intake is associated with increased faecal calprotectin levels: a randomised open-label clinical trial
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Rendek, Z.(1)*;Falk, M.(2);Grodzinsky, E.(1);Kechagias, S.(2);Hjortswang, H.(3);
Created: Friday, 14 July 2023, 10:48 AM
P203: Potential, novel serum biomarkers in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Kourkoulis*1, G. Michalopoulos1, H. Katifelis2, I. Papaconstantinou3, G. Karamanolis4, M. Gazouli2

Created: Friday, 22 February 2019, 9:41 AM
P203: Sexual Dysfunction in Chronic Inflammatory Bowel Disease: Myth or Reality?
Year: 2021
Source: ECCO'21 Virtual
Authors: Hassine, A.(1);Hammami, A.(1);Ben Ameur, W.(1);Dahmani, W.(1);Elleuch, N.(1);Jaziri, H.(1);Ben Slama, A.(1);Braham, A.(1);Ksiaa, M.(1);Bannour, R.(2);Jmaa, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P203: The performance of the Rutgeerts’ score, SES-CD, and MM-SES-CD for prediction of post-operative clinical recurrence in Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: Narula, N.(1);Wong, E.(1);Dulai, P.(2);Marshall, J.(1);Jairath, V.(3);Reinisch, W.(4);
Created: Friday, 11 February 2022, 3:52 PM
P203: Usefulness of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in clinical characterisation of children with newly diagnosed Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

U. Daniluk1*, J. Daniluk2, K. Guzinska-Ustymowicz3, A. Pryczynicz3, J. Sieczkowska-Golub4, J. Kierkus4, D. Lebensztejn1

Created: Thursday, 21 February 2019, 9:14 AM
P204 Re-established CRP cut-off in UC; it may be a better predictor of mucosal remission
Year: 2020
Source:

ECCO'20 Vienna

Authors:

O.K. Bakkaloglu, T. Eskazan, S. Bozcan, S. Yıldırım, E.A. Kurt, A.İ. Hatemi, Y. Erzin, F. Celik

Created: Thursday, 30 January 2020, 10:12 AM
P204: Elevated Fecal Calprotectin Levels Predict Flare-up in Patients with Inflammatory Bowel Disease During International Air Travel
Year: 2021
Source: ECCO'21 Virtual
Authors: Park, J.(1);Hyuk, Y.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P204: Endotrophin (PRO-C6) is associated with MRE confirmed intestinal strictures and Protein FingerPrint biomarkers of collagen degradation is associated with ulcerations in paediatric Crohn’s disease patients – results from the ImageKids study
Year: 2022
Source: ECCO'22
Authors: Mortensen, J.(1);Focht, G.(2);Pehrsson, M.(1);Griffiths, A.M.(3);Alexdóttir, M.S.(1);Church, P.C.(3);Baldassano, R.N.(4);Bay-Jensen, A.C.(1);Silverstein, J.(5);Karsdal, M.A.(1);Turner, D.(2);
Created: Friday, 11 February 2022, 3:52 PM
P204: Lipid profile in inflammatory bowel disease under maintenance wih anti-TNF: a prospective longitudinal cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ferreiro R., Lopez-Diaz J., Lorenzo A., Dominguez-Munoz J.E., Barreiro-de Acosta M.

Created: Wednesday, 20 February 2019, 10:36 AM
P204: Phenotypic and treatment characteristics of IBD patients with pseudopolyps in the era of biological treatments. Endoscopic characteristics of pseudopolyps are associated with the use of biological treatment: A multi-centre retrospective study
Year: 2018
Source: ECCO '18 Vienna
Authors:

D.S. Politis1, K.H. Katsanos1, K. Papamichael2, M. Choukour3, J. Tua4, A. Skamnelos1, V. Theopistos1, A. Kavvadias1, D. Balomenos1, G. Baltayiannis1, N. Tzabouras1, E.V. Tsianos1, L. Peyrin-Biroulet3, P. Ellul4, D.K. Christodoulou1*

Created: Thursday, 21 February 2019, 9:14 AM
P204: Preoperative optimization of patients with inflammatory bowel disease: a multicentre study of EIGA Group
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Molina Arriero, G.(1)*;Mauriz Barreiro, M.V.(1);Echarri Piudo, A.(1);Fraga Iriso, R.(1);González Furelos, T.(2);López de Ullibarri, I.(3);Vázquez Rey, M.T.(4);Calviño Suárez, C.(5);Carmona Campos, A.(6);Tejido Sandoval, C.(7);García Morales, N.(8);
Created: Friday, 14 July 2023, 10:48 AM